Downregulation of LINC00894-002 Contributes to Tamoxifen Resistance by Enhancing the TGF-β Signaling Pathway

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Biochemistry (Moscow)

• Publication date

  2018-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1134/S0006297918050139PMID 29738694
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells

  2019cited by this paper
• miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB

  2019cited by this paper
• GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

  2017cited by this paper
• Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205

  2017cited by this paper
• Suppression of long non-coding RNA CCAT2 improves tamoxifen-resistant breast cancer cells’ response to tamoxifen

  2016cited by this paper
• Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop

  2016cited by this paper
• The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression

  2016cited by this paper
• Dysregulation of long non-coding RNA in breast cancer: an overview of mechanism and clinical implication

  2016cited by this paper
• MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ*

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer

  2015cited by this paper
• TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer.

  2015cited by this paper
• MicroRNA biogenesis pathways in cancer

  2015cited by this paper
• A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma.

  2014cited by this paper
• Mechanism of cancer drug resistance and the involvement of noncoding RNAs.

  2014cited by this paper
• Reduced Expression of miR-200 Family Members Contributes to Antiestrogen Resistance in LY2 Human Breast Cancer Cells

  2013cited by this paper
• starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data

  2013cited by this paper
• The Long Noncoding RNA HOTAIR Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma Cells via downregualtion of p21WAF1/CIP1 Expression

  2013cited by this paper
• LNCipedia: a database for annotated human lncRNA transcript sequences and structures

  2012cited by this paper
• Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance

  2012cited by this paper
• Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells

  2011cited by this paper
• MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation

  2011cited by this paper
• The functional role of long non-coding RNA in human carcinomas

  2011cited by this paper
• Long noncoding RNAs: functional surprises from the RNA world.

  2009cited by this paper
• TGF‐Beta Signaling in Breast Cancer

  2006cited by this paper
• Sulforhodamine B colorimetric assay for cytotoxicity screening

  2006cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies

  2003cited by this paper
• Antisense oligonucleotides: basic concepts and mechanisms.

  2002cited by this paper
• Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.

  1999cited by this paper
• Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy.

  1996cited by this paper
• Oncotargets and Therapy Dovepress Tamoxifen in Early-stage Estrogen Receptor- Positive Breast Cancer: Overview of Clinical Use and Molecular Biomarkers for Patient Selection

  year unknowncited by this paper

• LINC00894, YEATS2-AS1, and SUGP2 genes as novel biomarkers for N0 status of lung adenocarcinoma

  2025cites this paper
• Sex effects on gene expression across the human cerebral cortex at single cell resolution

  2025cites this paper
• Mechanisms of tamoxifen resistance: insight from long non-coding RNAs

  2024cites this paper
• LINC00894 Regulates Cerebral Ischemia/Reperfusion Injury by Stabilizing EIF5 and Facilitating ATF4-Mediated Induction of FGF21 and ACOD1 Expression

  2024cites this paper
• LINC00894 inhibited neuron cellular apoptosis and regulated activating transcription factor 3 expression.

  2024cites this paper
• Harnessing the potential of long non-coding RNAs in breast cancer: from etiology to treatment resistance and clinical applications

  2024cites this paper
• Therapeutic significance of long noncoding RNAs in estrogen receptor‐positive breast cancer

  2024cites this paper
• LINC00894 targets Annexin A2 to regulate oxaliplatin resistance in hepatocellular carcinoma: ANXA2 protein function.

  2024cites this paper
• The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms

  2023cites this paper
• Roles of TGF‑β signalling pathway‑related lncRNAs in cancer (Review)

  2023cites this paper
• The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer

  2022cites this paper
• Regulatory functions of miR-200b-3p in tumor development

  2022cites this paper
• Prognostic and Predictive Effects of Tumor and Plasma miR-200c-3p in Locally Advanced and Metastatic Breast Cancer

  2022cites this paper
• Elevated LINC00894 relieves the oncogenic properties of thyroid cancer cell by sponging let-7e-5p to promote TIA-1 expression

  2022cites this paper
• Genome-wide analysis of the FOXA1 transcriptional regulatory network identifies super enhancer associated LncRNAs in tamoxifen resistance

  2022cites this paper
• CCAT2 knockdown inhibits cell growth, and migration and promotes apoptosis through regulating the hsa-mir-145-5p/AKT3/mTOR axis in tamoxifen-resistant MCF7 cells.

  2022cites this paper
• The tamoxifen-regulated, long non-coding RNA LINC00992 affects proliferation, migration, and expression of tamoxifen resistance-associated genes in MCF-7 breast cancer cells

  2022cites this paper
• Somatic point mutations are enriched in non-coding RNAs with possible regulatory function in breast cancer

  2021cites this paper
• Role of TGF-β signaling in the mechanisms of tamoxifen resistance.

  2021cites this paper
• Identification of LINC00173 in Myasthenia Gravis by Integration Analysis of Aberrantly Methylated- Differentially Expressed Genes and ceRNA Networks

  2021cites this paper
• From Micro to Long: Non-Coding RNAs in Tamoxifen Resistance of Breast Cancer Cells

  2021cites this paper
• The Construction and Analysis of ceRNA Network and Immune Infiltration in Kidney Renal Clear Cell Carcinoma

  2021cites this paper
• Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs.

  2020cites this paper
• Exosomes Mediated Transfer of Circ_UBE2D2 Enhances the Resistance of Breast Cancer to Tamoxifen by Binding to MiR-200a-3p

  2020cites this paper
• Long Non-Coding RNAs in Drug Resistance of Breast Cancer

  2020cites this paper
• Identification and Analysis of Estrogen Receptor α Promoting Tamoxifen Resistance-Related lncRNAs

  2020cites this paper
• The Role of Long Noncoding RNAs in Antiestrogen Resistance in Breast Cancer: An Overview and Update

  2020cites this paper
• UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells

  2019cites this paper
• Construction of ceRNA networks reveals differences between distal and proximal colon cancers.

  2019cites this paper
• Non-coding RNAs as Mediators of Tamoxifen Resistance in Breast Cancers.

  2019cites this paper
• miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB

  2019cites this paper
• Long non-coding RNA LINC00472 suppresses hepatocellular carcinoma cell proliferation, migration and invasion through miR-93-5p/PDCD4 pathway.

  2019cites this paper
• The Construction and Analysis of ceRNA Network and Immune In�ltration in Kidney Renal Clear Cell Carcinoma

  year unknowncites this paper